The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study

Abstract

The CONTRAST-AMI study will provide information on the effects of iodixanol and iopromide on the incidence of CI-AKI and tissue-level perfusion in patients with AMI.

Contrast-Induced Acute Kidney Injury: The At-Risk Patient and Protective Measures

“…Larger head-to-head randomized trials need to be conducted to determine the efficacy of iso-osmolar agents such as iodixanol over the less expensive lowosmolar agents. The CONTRAST-AMI (Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction) study has been revealed as such a study to evaluate iopromide as a low-osmolar agent compared with iodixanol as an iso-osmolar agent for CI-AKI and tissue-level perfusion among patients with ST-segment myocardial infarctions [31].…”

Out-of-hospital cardiac arrest: data from the National Registry of Invasive Cardiology Procedures (ORPKI) in a long-term survival analysis of patients with acute coronary syndromes in a Polish region

“…Unfavorable effects of contrast agents administered during invasive procedures are known through their impact on renal function. 29 No data could be found in the literature on the effects of the total amount of contrast agents administered during invasive procedures on survival in patients with ACS who had OHCA. Registries of ACSs may serve as a basis for analysis of various medical events, such as OHCA in the present study.…”